University Hospitals Birmingham NHS Foundation Trust

Reports

Status Drug name NICE TAs Comments
Status: Red Thiotepa injection

For hospital use only

Status: Green Timodine cream

Mild steroid potency

Status: Amber Timolol 0.1% unit dose eye gel (Tiopex)

Specialist ophthalmologist recommendation

Status: Amber Timolol 0.25% eye drops

Specialist ophthalmologist recommendation

Status: Amber Timolol LA eye drops

Specialist ophthalmologist recommendation

Status: Green Tiotropium

Prescribe by brand to ensure patients receive the device they are used to. Check licensed indication (differences among brands). Be aware of differences in excipients among the different brands - APC listing of current formulary brands

Status: Green Tiotropium and Olodaterol (Spiolto® Respimat®)

For COPD

Status: Red Tisseel

Hospital use only

Status: Amber Tobramycin nebulised

NHS England Commissioned for Cystic Fibrosis only. Existing patients - initiated prior to April 2013

Status: Red Tobramycin nebulised

NHS England Commissioned for Cystic Fibrosis only, new patients

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.

Building healthier lives
Back to top